Published in Nephrol Dial Transplant on July 26, 2005
Association of metabolic syndrome with development of new-onset diabetes after transplantation. Transplantation (2010) 2.20
Cytomegalovirus-induced immunopathology and its clinical consequences. Herpesviridae (2011) 1.19
New onset diabetes after transplantation (NODAT): an overview. Diabetes Metab Syndr Obes (2011) 1.13
Novel views on new-onset diabetes after transplantation: development, prevention and treatment. Nephrol Dial Transplant (2013) 0.97
Cytomegalovirus seropositivity is associated with glucose regulation in the oldest old. Results from the Leiden 85-plus Study. Immun Ageing (2012) 0.89
Risk factors for new-onset diabetes after kidney transplantation. Nat Rev Nephrol (2010) 0.82
Direct and Indirect Effects of Cytomegalovirus-Induced γδ T Cells after Kidney Transplantation. Front Immunol (2015) 0.81
The impact of cytomegalovirus infection on new-onset diabetes mellitus after kidney transplantation: a review on current findings. J Nephropathol (2014) 0.79
Post-Transplant Diabetes Mellitus: Causes, Treatment, and Impact on Outcomes. Endocr Rev (2015) 0.76
Effects of oral valganciclovir prophylaxis for cytomegalovirus infection in heart transplant patients. Drug Des Devel Ther (2012) 0.76
Correlation between CMV Infection and Post-transplantation New-onset Diabetes Mellitus. Int J Organ Transplant Med (2016) 0.75
Effect of valsartan on the incidence of diabetes and cardiovascular events. N Engl J Med (2010) 5.46
Effect of nateglinide on the incidence of diabetes and cardiovascular events. N Engl J Med (2010) 4.38
Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial. Lancet (2003) 4.19
Estimated GFR associates with cardiovascular risk factors independently of measured GFR. J Am Soc Nephrol (2011) 2.25
Limitations of hemoglobin A1c for the diagnosis of posttransplant diabetes mellitus. Transplantation (2015) 2.00
Association of albuminuria and cancer incidence. J Am Soc Nephrol (2008) 1.91
Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation. Transplantation (2009) 1.79
Impact of genetic polymorphisms in cytomegalovirus glycoprotein B on outcomes in solid-organ transplant recipients with cytomegalovirus disease. Clin Infect Dis (2009) 1.64
Parathyroid hormone, but not vitamin D, is associated with the metabolic syndrome in morbidly obese women and men: a cross-sectional study. Cardiovasc Diabetol (2009) 1.62
Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival. Kidney Int (2004) 1.57
Pre-transplant Toxoplasma gondii seropositivity among heart transplant recipients is associated with an increased risk of all-cause and cardiac mortality. J Am Coll Cardiol (2007) 1.48
Short-term treatment with rosiglitazone improves glucose tolerance, insulin sensitivity and endothelial function in renal transplant recipients. Nephrol Dial Transplant (2004) 1.46
Short-term efficacy and safety of sitagliptin treatment in long-term stable renal recipients with new-onset diabetes after transplantation. Nephrol Dial Transplant (2014) 1.45
Vitamin status in morbidly obese patients: a cross-sectional study. Am J Clin Nutr (2008) 1.43
The impact of short-term ciclosporin A treatment on insulin secretion and insulin sensitivity in man. Nephrol Dial Transplant (2007) 1.43
Diagnosing PTDM. Transplantation (2002) 1.37
The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients. Am J Transplant (2002) 1.36
Comparing mycophenolate mofetil regimens for de novo renal transplant recipients: the fixed-dose concentration-controlled trial. Transplantation (2008) 1.34
Stromal cell-derived factor-1alpha in unstable angina: potential antiinflammatory and matrix-stabilizing effects. Circulation (2002) 1.32
Predictors of change in estimated GFR: a population-based 7-year follow-up from the Tromso study. Nephrol Dial Transplant (2008) 1.30
Albuminuria as risk factor for initiation and progression of carotid atherosclerosis in non-diabetic persons: the Tromsø Study. Eur Heart J (2006) 1.27
Impaired secretion of IL-10 by T cells from patients with common variable immunodeficiency--involvement of protein kinase A type I. J Immunol (2003) 1.25
Enhanced T-cell expression of RANK ligand in acute coronary syndrome: possible role in plaque destabilization. Arterioscler Thromb Vasc Biol (2006) 1.21
Insulin resistance after renal transplantation: the effect of steroid dose reduction and withdrawal. J Am Soc Nephrol (2004) 1.13
Inflammatory mediators in morbidly obese subjects: associations with glucose abnormalities and changes after oral glucose. Eur J Endocrinol (2009) 1.13
Increased expression of toll-like receptor 2 on monocytes in HIV infection: possible roles in inflammation and viral replication. Clin Infect Dis (2004) 1.11
Enhanced expression of inflammatory cytokines and activation markers in T-cells from patients with chronic heart failure. Cardiovasc Res (2003) 1.10
Assessment of renal allograft fibrosis by acoustic radiation force impulse quantification--a pilot study. Transpl Int (2010) 1.10
Clinical outcomes in elderly kidney transplant recipients are related to acute rejection episodes rather than pretransplant comorbidity. Transplantation (2009) 1.09
Overall and cardiovascular mortality in Norwegian kidney donors compared to the background population. Nephrol Dial Transplant (2011) 1.08
[Re: Hearing loss in children in Östfold county 2000-09]. Tidsskr Nor Laegeforen (2015) 1.08
Acute renal failure early after heart transplantation: risk factors and clinical consequences. Clin Transplant (2010) 1.07
The clinical utility of whole blood versus plasma cytomegalovirus viral load assays for monitoring therapeutic response. Transplantation (2011) 1.07
CYP3A5 genotype is not associated with a higher risk of acute rejection in tacrolimus-treated renal transplant recipients. Pharmacogenet Genomics (2008) 1.07
Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir. Antivir Ther (2009) 1.05
[Increased risk of myocardial infarction following rosiglitazone?]. Tidsskr Nor Laegeforen (2007) 1.05
Prevalence of reverse transcriptase and protease mutations associated with antiretroviral drug resistance among drug-naïve HIV-1 infected pregnant women in Kagera and Kilimanjaro regions, Tanzania. AIDS Res Ther (2008) 1.04
Benefit of kidney transplantation beyond 70 years of age. Nephrol Dial Transplant (2009) 1.02
Characterization of human cytomegalovirus uracil DNA glycosylase (UL114) and its interaction with polymerase processivity factor (UL44). J Mol Biol (2008) 1.02
Low serum creatinine is associated with type 2 diabetes in morbidly obese women and men: a cross-sectional study. BMC Endocr Disord (2010) 1.01
Undiagnosed diabetes in kidney transplant candidates: a case-finding strategy. Clin J Am Soc Nephrol (2010) 1.01
Disturbances in beta-cell function in impaired fasting glycemia. Diabetes (2002) 1.01
A 6-year prospective study on new onset diabetes mellitus, insulin release and insulin sensitivity in renal transplant recipients. Nephrol Dial Transplant (2003) 1.01
Interleukin-10 enhances the oxidized LDL-induced foam cell formation of macrophages by antiapoptotic mechanisms. J Lipid Res (2004) 1.00
Intermittent saline flushes during haemodialysis do not alleviate coagulation and clot formation in stable patients receiving reduced doses of dalteparin. Nephrol Dial Transplant (2005) 1.00
Incidence and outcomes of ganciclovir-resistant cytomegalovirus infections in 1244 kidney transplant recipients. Transplantation (2011) 1.00
Abnormal interleukin-7 function in common variable immunodeficiency. Blood (2004) 0.99
Albuminuria and risk of nonvertebral fractures. Arch Intern Med (2007) 0.99
Effect of immune modulation on TT virus (TTV) and TTV-like-mini-virus (TLMV) viremia. J Med Virol (2003) 0.98
Uric acid is a risk factor for ischemic stroke and all-cause mortality in the general population: a gender specific analysis from The Tromsø Study. BMC Cardiovasc Disord (2013) 0.97
The natural course of cytomegalovirus infection and disease in renal transplant recipients. Transplantation (2006) 0.97
Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation. Transpl Int (2005) 0.97
Recurrent lupus nephritis after kidney transplantation: a surveillance biopsy study. Ann Rheum Dis (2010) 0.97
Leptotrichia amnionii, an emerging pathogen of the female urogenital tract. J Clin Microbiol (2007) 0.96
[Prehospital diagnosis and treatment of acute myocardial infarction in Vestfold]. Tidsskr Nor Laegeforen (2004) 0.96
Serglycin is a major proteoglycan in polarized human endothelial cells and is implicated in the secretion of the chemokine GROalpha/CXCL1. J Biol Chem (2010) 0.96
Early posttransplant serum osteoprotegerin levels predict long-term (8-year) patient survival and cardiovascular death in renal transplant patients. J Am Soc Nephrol (2006) 0.95
Disturbed glutathione metabolism and decreased antioxidant levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy--potential immunomodulatory effects of antioxidants. J Infect Dis (2003) 0.94
Diversity of human immunodeficiency virus type 1 subtypes in Kagera and Kilimanjaro regions, Tanzania. AIDS Res Hum Retroviruses (2008) 0.94
Glycated hemoglobin level is strongly related to the prevalence of carotid artery plaques with high echogenicity in nondiabetic individuals: the Tromsø study. Circulation (2004) 0.94
The risk of living kidney donation. Nephrol Dial Transplant (2003) 0.94
Morbidly obese patients--who undergoes bariatric surgery? Obes Surg (2010) 0.94
Virologic suppression measured by a cytomegalovirus (CMV) DNA test calibrated to the World Health Organization international standard is predictive of CMV disease resolution in transplant recipients. Clin Infect Dis (2013) 0.92
Reduced incidence of new-onset posttransplantation diabetes mellitus during the last decade. Transplantation (2007) 0.92
Physical exercise, fasting glucose, and renal hyperfiltration in the general population: the Renal Iohexol Clearance Survey in Tromsø 6 (RENIS-T6). Clin J Am Soc Nephrol (2012) 0.91
Peripheral neuropathy and severe malnutrition following duodenal switch. Obes Surg (2008) 0.91
Impaired base excision repair and accumulation of oxidative base lesions in CD4+ T cells of HIV-infected patients. Blood (2005) 0.91
Impact of instrument error on the estimated prevalence of overweight and obesity in population-based surveys. BMC Public Health (2013) 0.90
CD11c+ dendritic cells and plasmacytoid DCs are activated by human cytomegalovirus and retain efficient T cell-stimulatory capability upon infection. Blood (2005) 0.90
Fasting plasma glucose in the screening for type 2 diabetes in morbidly obese subjects. Obes Surg (2009) 0.90
Early versus late acute antibody-mediated rejection in renal transplant recipients. Transplantation (2013) 0.89